Physician profile
Vamsee M Yaganti
NPI 1255591194
$390,153.92
in general payments reported to CMS, 2019-2025
26 companies · $125K in 2025
The $125K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $11K · 2021: $4,580 · 2022: $91K · 2023: $72K · 2024: $73K · 2025: $125K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $123K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $91K · Travel and Lodging: $25K · Food and Beverage: $19K · Grant: $14K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $122,615.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $90,500.00 |
| Travel and Lodging | $24,748.71 |
| Food and Beverage | $19,214.24 |
| Grant | $13,525.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $199,380.59 | 2019-2025 | Watchman, Watchman Flx, Watchman Access System |
| W. L. Gore & Associates, INC. | $125,365.68 | 2019-2025 | Gore Cardioform Septal Occluder, Gore Cardioform Asd Occluder, Product In Development |
| Edwards Lifesciences Corporation | $49,533.33 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Evoque |
| Abbott Laboratories | $6,990.58 | 2019-2025 | Mitraclip, Navitor, Triclip |
| Recor Medical INC | $3,909.43 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Abiomed | $1,972.12 | 2021-2024 | Impella |
| Medtronic, INC. | $1,148.53 | 2023-2025 | Corevalve Evolut R, Adapta, Micra |
| Philips North America LLC | $785.93 | 2022-2024 | (Bs3) Intracardiac Und, (P84) Igt Devices Systems, (9520) Igt Devices Und |
| Medtronic Vascular, INC. | $343.41 | 2019-2020 | |
| Teleflex LLC | $144.17 | 2023 | Manta |
| E.R. Squibb & Sons, L.L.C. | $107.91 | 2020-2024 | Camzyos |
| Amgen INC. | $83.42 | 2023-2024 | Repatha |
| Pfizer INC. | $83.32 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $53.63 | 2019-2025 | |
| Biotronik INC. | $45.22 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $32.83 | 2025 | Wegovy |
| Inspire Medical Systems, INC. | $26.85 | 2023 | Inspire |
| Impulse Dynamics (USA) INC. | $24.13 | 2020 | |
| Chiesi USA, INC. | $20.47 | 2025 | Kengreal |
| Heartflow, INC. | $20.27 | 2025 | |
| Bard Peripheral Vascular, INC. | $15.85 | 2025 | True Flow |
| Lantheus Medical Imaging, INC. | $14.83 | 2020 | |
| Circassia INC. | $14.77 | 2019 | |
| Amarin Pharma, INC. | $14.71 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.94 | 2020 | |
| Penumbra, INC. | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vamsee Yaganti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.